CRC
CL icon

Curi RMB Capital’s Colgate-Palmolive CL Stock Holding History

Curi RMB Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$566K Sell
6,175
-120
-2% -$10.5K 0.01% 575
2026
Q1 		$537K Buy
6,295
+454
+8% +$40.5K 0.01% 584
2025
Q4 		$462K Buy
5,841
+883
+18% +$69.2K 0.01% 636
2025
Q3 		$396K Sell
4,958
-31
-0.6% -$2.64K 0.01% 553
2025
Q2 		$453K Buy
+4,989
New +$455K 0.01% 528
2024
Q4 		– Sell
-1,959
Closed -$203K – 522
2024
Q3 		$203K Sell
1,959
-3,746
-66% -$382K ﹤0.01% 531
2024
Q2 		$554K Buy
5,705
+850
+18% +$78.4K 0.01% 407
2024
Q1 		$437K Sell
4,855
-59
-1% -$5K 0.01% 451
2023
Q4 		$392K Sell
4,914
-16
-0.3% -$1.2K 0.01% 410
2023
Q3 		$351K Buy
4,930
+13
+0.3% +$972 0.01% 412
2023
Q2 		$379K Buy
4,917
+6
+0.1% +$464 0.01% 405
2023
Q1 		$369K Sell
4,911
-826
-14% -$61.4K 0.01% 400
2022
Q4 		$452K Buy
5,737
+39
+0.7% +$2.92K 0.02% 375
2022
Q3 		$400K Buy
5,698
+3,201
+128% +$251K 0.01% 379
2022
Q2 		$200K Buy
+2,497
New +$195K 0.01% 460
2022
Q1 		– Sell
-2,397
Closed -$205K – 441
2021
Q4 		$205K Buy
+2,397
New +$187K 0.01% 444
2019
Q2 		– Sell
-5,406
Closed -$371K – 760
2019
Q1 		$371K Buy
5,406
+181
+3% +$11.7K 0.01% 633
2018
Q4 		$311K Sell
5,225
-4
-0.1% -$250 0.01% 733
2018
Q3 		$350K Sell
5,229
-275
-5% -$18.3K 0.01% 694
2018
Q2 		$357K Sell
5,504
-207
-4% -$13.5K 0.01% 685
2018
Q1 		$409K Sell
5,711
-3,928
-41% -$283K 0.01% 666
2017
Q4 		$727K Hold
9,639
– – 0.02% 537
2017
Q3 		$702K Buy
9,639
+494
+5% +$35.6K 0.02% 474
2017
Q2 		$678K Buy
9,145
+298
+3% +$22.1K 0.02% 492
2017
Q1 		$647K Buy
8,847
+1,510
+21% +$106K 0.03% 343
2016
Q4 		$480K Buy
+7,337
New +$503K 0.03% 316

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Curi RMB Capital's CL Position: Q2 2026 in Review

Curi RMB Capital reduced its Colgate-Palmolive (CL) stake by 1.9% in Q2 2026, selling an estimated $10.5K and leaving 6,175 shares worth $566K. The position accounts for 0.01% of the portfolio, ranked #575.

Curi RMB Capital first reported a position in CL in Q4 2016 and has held it in 26 quarters since. The position peaked at $727K in Q4 2017. 2,027 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Curi RMB Capital held 6,175 shares of Colgate-Palmolive worth $566K as of Q2 2026.
  • Curi RMB Capital sold 120 Colgate-Palmolive shares in Q2 2026, an estimated $10.5K.
  • Colgate-Palmolive made up 0.01% of Curi RMB Capital's portfolio in Q2 2026, its #575 holding.
  • Curi RMB Capital first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 26 quarters since.
  • Curi RMB Capital's Colgate-Palmolive position peaked at $727K in Q4 2017.
  • 2,027 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.